Clinical Trial Update: Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1) [Phase 2]

View source ↗

Summary

Phase 2 trial of subcutaneously administered CM310 versus placebo in chronic rhinosinusitis with nasal polyposis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps
• Rhinosinusitis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Rhinosinusitis (Diagnosis), Nasal Polyps | Phase 2 | Status: COMPLETED